Analysis of human melanoma trials from publicly available databases show that intratumoral CD11c expression correlates with increased CD8+ T-cell infiltration (Fig. 1F), especially effector/memory subtypes (Fig. 2B), and that patients with more expression have improved survival outcomes (Supp Fig. 3) and better responses to immune checkpoint inhibitor therapy (Supp Fig. 4). This evidence concerns the gene ITGAX and melanoma.